HomeInsightsMarket Capitalization

Market Capitalization of Dr Reddys Laboratories Ltd

Market Capitalization of Dr Reddys Laboratories Ltd

stocks purchased

₹ 27.7 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

206.5 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Market Cap

₹ 112015.49 crore

Last updated on: Dec 20, 2024

Key Highlights

  • The Market Cap of Dr Reddys Laboratories Ltd is ₹ 112015 crore as of 20 Dec 24 .
  • The Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 46069 crore on March 2019 to ₹ 102679 crore on March 2024 . This represents a CAGR of 14.29% over 6 years.
  • The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1342 as of 20 Dec 15:30 .
  • The Dividend Payouts of Dr Reddys Laboratories Ltd changed from ₹ 20 on Jul 15, 2019 to ₹ 40 on Jul 16, 2024 . This represents a CAGR of 12.25% over 6 years.

Historical Market Cap of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Company Fundamentals for Dr Reddys Laboratories Ltd

No data available

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Share Price

₹ 1342.45

16.45 (1.24%)

stock direction

Last updated on: Dec 20, 2024

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20241342.45
19 Dec 20241326
18 Dec 20241275.05
17 Dec 20241248
16 Dec 20241269.9
13 Dec 20241246.3
12 Dec 20241245.95
11 Dec 20241238.45
10 Dec 20241239.95
09 Dec 20241254.8

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Dr Reddys Laboratories Ltd

No data available

No data available

Historical P/E Ratio of Dr Reddys Laboratories Ltd

No data available

* All values are in %

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Dr Reddys Laboratories Ltd

No data available

* All values are in

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories was incorporated in the year 1984 in Hyderabad.

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories allots 13,080 equity shares under ESOS

Dr Reddys Laboratories has allotted 13,080 equity shares under ESOS on 19 December 2024. P...

Read more

20 Dec 2024 09:31

News

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting...

Read more

20 Dec 2024 13:05

News

Dr Reddys launches immuno-oncology drug - Toripalimab in India

Dr Reddys Laboratories announced the launch of Toripalimab in India. Toripalimab is a New ...

Read more

28 Nov 2024 09:14

News

Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India

Toripalimab is the only immuno-oncology drug approved by various regulatory authorities ar...

Read more

28 Nov 2024 10:11

News

DRL slips after Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

21 Nov 2024 10:23

News

DRL's Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

20 Nov 2024 10:40

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Dr Reddys Laboratories Ltd Market Cap

What is the market cap of Dr Reddys Laboratories Ltd?

As of December 22, 2024, Dr Reddys Laboratories Ltd has a market capitalization of ₹112015.49, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Dr Reddys Laboratories Ltd's market capitalization?

Dr Reddys Laboratories Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Dr Reddys Laboratories Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Dr Reddys Laboratories Ltd's market capitalization change?

Dr Reddys Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions